Microarray Technology and Cancer Gene Profiling

Cancer is a heterogeneous disease in most respects, including its cellularity, different genetic alterations and diverse clinical behaviors. Traditional molecular analyses are reductionist, assessing only one or a few genes at a time, thus working with a biologic model too specific and limited to co...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Mocellin, Simone (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: New York, NY : Springer New York, 2007.
Σειρά:Advances in Experimental Medicine and Biology, 593
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03708nam a22004575i 4500
001 978-0-387-39978-2
003 DE-He213
005 20151204165651.0
007 cr nn 008mamaa
008 100301s2007 xxu| s |||| 0|eng d
020 |a 9780387399782  |9 978-0-387-39978-2 
024 7 |a 10.1007/978-0-387-39978-2  |2 doi 
040 |d GrThAP 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Microarray Technology and Cancer Gene Profiling  |h [electronic resource] /  |c edited by Simone Mocellin. 
264 1 |a New York, NY :  |b Springer New York,  |c 2007. 
300 |a XVIII, 159 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 593 
505 0 |a Microarray Technology -- Manufacturing of Microarrays -- Technological Platforms for Microarray Gene Expression Profiling -- Principles of Gene Microarray Data Analysis -- Gaining Weights ... and Feeling Good about It! -- Complementary Techniques -- Complementary Techniques -- Complementary Techniques -- Applications in the Oncology Field -- Microarrays for Cancer Diagnosis and Classification -- Gene Profiling for the Prediction of Tumor Response to Treatment -- Identification of Molecular Determinants of Tumor Sensitivity and Resistance to Anticancer Drugs -- SNP and Mutation Analysis -- Cancer Development and Progression -- Gene Expression Profiling in Malignant Lymphomas -- Tumor Immunology. 
520 |a Cancer is a heterogeneous disease in most respects, including its cellularity, different genetic alterations and diverse clinical behaviors. Traditional molecular analyses are reductionist, assessing only one or a few genes at a time, thus working with a biologic model too specific and limited to confront a process whose clinical outcome is likely to be governed by the combined influence of many genes. The potential of functional genomics is enormous, because for each experiment, thousands of relevant observations can be made simultaneously. Accordingly, DNA array, as other high throughput technologies, might catalyze and ultimately accelerate the development of knowledge in tumor cell biology. Although in its infancy, the implementation of DNA array technology in cancer research has already provided investigators with novel data and intriguing new hypotheses on the molecular cascade leading to cancerogenesis, tumor aggressiveness and sensitivity to antineoplastic agents. Given the revolutionary implications that the use of this technology might have in the clinical management of cancer patients, principles of DNA array-based tumor gene profiling need to be clearly understood for the data to be correctly interpreted and appreciated. In the present book, written by leading experts in each field, the technical features characterizing this powerful laboratory tool are discussed, and the applications so far described in the field of oncology are reviewed. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Oncology. 
650 2 4 |a Cancer Research. 
700 1 |a Mocellin, Simone.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9780387399775 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 593 
856 4 0 |u http://dx.doi.org/10.1007/978-0-387-39978-2  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)